MARISSA DIGREGORIO: Open Payments
NPI 1700561321 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 37 payments from 16 companies in 2025. Trend: 2023 $16 · 2024 $528 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 1 | $149 |
| ABBVIE INC. | 7 | $148 |
| Lilly USA, LLC | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $58 |
| Novo Nordisk Inc | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Exact Sciences Corporation | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 1 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
Products named: TWIIST, QULIPTA, XIFAXAN, REXULTI, Cologuard Collection Kit, VOQUEZNA, UBRELVY, SHINGRIX.
Industry payments across MO — which companies pay providers there.
